Aguanta, Beverly C.
HRN: 12-30-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2023
LEVOFLOXACIN 500MG (TAB)
01/21/2023
01/27/2023
PO
500mg Tab
OD
Pneumonja
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes